Hepatitis C is an infection of the liver caused by the hepatitis C virus (HCV). Experts estimate that about 2.4 million people in the United States are living with hepatitis C—but that figure could be ...

The American Association for the Study of Liver Diseases, along with other societies, has updated guidelines for the treatment of hepatitis C viral infection (HCV), including the use of direct-acting ...

A case of a 45-year-old construction worker with a history of intravenous drug use, homelessness, and occasional alcohol and tobacco use.

Among rural people with chronic HCV infection and a history of injection drug use, a mobile telemedicine-based intervention vs enhanced usual care improves treatment initiation and cure rates.

Results of a phase IIIb study found the direct-acting antiviral combination of glecaprevir/pibrentasvir to be highly effective and well tolerated in adults with acute ...

Pharmacological treatment is recommended for patients with chronic HCV infection, advanced fibrosis, compensated cirrhosis, liver transplant, severe extrahepatic manifestations, HIV co-infection, or ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Of those who completed treatment, 92% had undetectable ...

Treating hepatitis C virus (HCV) earlier in kids was associated with better lifetime clinical outcomes and lower healthcare costs compared with deferring treatment, a modeling study showed. Projected ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — In this video, Nancy S. Reau, MD, FAASLD, AGAF, reviews three abstracts presented at The Liver Meeting ...